Customs exemption for imports used in bulk drug manufacture limits customs and additional duty on specified inputs. The notification exempts specified imported goods, when imported for manufacture of listed bulk drugs, from so much of the customs duty in the First Schedule as exceeds the amount calculated at the rate of 10% ad valorem and from the whole of the additional duty leviable under section 3 of the Customs Tariff Act. The exemption is granted under sub section (1) of section 25 of the Customs Act, 1962 and applies only to goods described in the annexed Table corresponding to named bulk drugs such as Rifampicin.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Customs exemption for imports used in bulk drug manufacture limits customs and additional duty on specified inputs.
The notification exempts specified imported goods, when imported for manufacture of listed bulk drugs, from so much of the customs duty in the First Schedule as exceeds the amount calculated at the rate of 10% ad valorem and from the whole of the additional duty leviable under section 3 of the Customs Tariff Act. The exemption is granted under sub section (1) of section 25 of the Customs Act, 1962 and applies only to goods described in the annexed Table corresponding to named bulk drugs such as Rifampicin.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.